News Image

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

Provided By PR Newswire

Last update: Jul 15, 2025

Agreement with global pharmaceutical solutions provider enhances commercial infrastructure and reinforces launch readiness for FDA-approved immunotherapy LYMPHIRâ„¢

Read more at prnewswire.com

CITIUS PHARMACEUTICALS INC

NASDAQ:CTXR (10/10/2025, 9:19:26 PM)

After market: 1.22 -0.01 (-0.81%)

1.23

-0.05 (-3.91%)


CITIUS ONCOLOGY INC

NASDAQ:CTOR (10/10/2025, 9:19:24 PM)

After market: 1.84 +0.13 (+7.6%)

1.71

-0.12 (-6.56%)



Find more stocks in the Stock Screener

Follow ChartMill for more